AAMU
VCYT icon

Amundi Asset Management US’s Veracyte VCYT Stock Holding History

Amundi Asset Management US’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,000
Closed -$134K – 1668
2018
Q3 		$134K Buy
+14,000
New +$154K ﹤0.01% 1497

Other funds holding VCYT

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Amundi Asset Management US's VCYT Position: Q4 2018 in Review

Amundi Asset Management US sold out of Veracyte (VCYT) in Q4 2018, closing a stake of 14,000 shares — an estimated $134K sold.

Amundi Asset Management US first reported a position in VCYT in Q3 2018 and held it in 1 quarter. The position peaked at $134K in Q3 2018. 125 funds tracked by Wall St. Rank hold VCYT as of Q4 2018.

  • Amundi Asset Management US reported no remaining Veracyte position as of Q4 2018 after selling out during the quarter.
  • Amundi Asset Management US sold 14,000 Veracyte shares in Q4 2018, an estimated $134K.
  • Amundi Asset Management US first reported a position in Veracyte in Q3 2018 and held it in 1 quarter.
  • Amundi Asset Management US's Veracyte position peaked at $134K in Q3 2018.
  • 125 funds tracked by Wall St. Rank held Veracyte as of Q4 2018.

Based on Amundi Asset Management US's 13F filing for Q4 2018, filed 14 Feb 2019.